MELK is a novel therapeutic target in high-risk neuroblastoma.
Guan S, Lu J, Zhao Y, Yu Y, Li H, Chen Z, Shi Z, Liang H, Wang M, Guo K, Chen X, Sun W, Bieerkehazhi S, Xu X, Sun S, Agarwal S, Yang J.
Guan S, et al. Among authors: zhao y.
Oncotarget. 2017 Dec 20;9(2):2591-2602. doi: 10.18632/oncotarget.23515. eCollection 2018 Jan 5.
Oncotarget. 2017.
PMID: 29416794
Free PMC article.